Membrane Tyrosine Kinase Receptors are an Important Target for the Therapy of Acute Myeloid Leukemia

Publisher： Bentham Science Publishers

E-ISSN： 1875-6301|4|1|31-49

ISSN： 1573-3947

Source： Current Cancer Therapy Reviews, Vol.4, Iss.1, 2008-02, pp. : 31-49

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Membrane Tyrosine Kinase Receptors Kit and FLT3 are an Important Targets for the Therapy of Acute Myeloid Leukemia

By  

Current Cancer Therapy Reviews, Vol. 9, Iss. 3, 2013-08 ,pp. : 181-219

Bentham Science Publishers

Access to resources Recommend Favorite

Tyrosine kinase inhibition in acute myeloid leukemia

By Altman Jessica K.   Szilard Amy K.   Platanias Leonidas C.  

Leukemia and Lymphoma, Vol. 54, Iss. 7, 2013-07 ,pp. : 1351-1352

Informa Healthcare

Access to resources Recommend Favorite

Chronic Myeloid Leukemia: The Value of Tyrosine Kinase Inhibition

By Tariq I. Mughal   John M. Goldman  

American Journal of Cancer, Vol. 2, Iss. 5, 2003-01 ,pp. : 305-311

Adis International

Access to resources Recommend Favorite

Tyrosine Kinase Inhibitors for the Treatment of Chronic Myeloid Leukemia

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 9, Iss. 8, 2009-10 ,pp. : 853-863

Bentham Science Publishers

Access to resources Recommend Favorite

Synergistic effect of alltrans retinoic acid in combination with protein kinase C 412 in FMS-like tyrosine kinase 3-mutated acute myeloid leukemia cells

By            

Molecular Medicine Reports, Vol. 11, Iss. 5, 2015-01 ,pp. : 3969-3975

Spandidos Publications

Access to resources Recommend Favorite